Your 'max strength' labels are probably illegal lies
That "max strength" cold medicine might be a rip-off, and courts just said consumers can sue over those hyped-up labels.
By Foodie Pundit Newsroom - Published - Updated - Section: Policy Regulation
Key points
- The Second Circuit revived claims that 'maximum strength' branding is misleading to consumers.
- Corporate giants are no longer shielded by federal preemption if their marketing is deemed deceptive.
- The ruling sets a precedent that could impact 'functional' food and beverage labels like 'superfood' or 'extra strong'.
- Independent operators need to audit their own menu claims as consumer trust in corporate branding hits a new low.
The courtroom drama surrounding what we put in our bodies just took a massive turn in the U.S. Court of Appeals for the Second Circuit. While the case technically centers on oral decongestants, the implications are vibrating through every aisle of the grocery store and every shelf of the local bodega. The court has officially revived claims that calling a product maximum strength might actually be a load of corporate puffery if the science behind it does not hold up.
For years, consumers have walked into drugstores and supermarkets looking for relief, whether that is from a seasonal cold or the lingering effects of a late night out. We trust the labels. When a box says maximum strength, we assume we are getting the most effective version of that medicine allowed by law. However, a multidistrict litigation (MDL) has been brewing, alleging that these claims were fundamentally misleading.
The Second Circuit recently handed down a ruling that is a bit of a mixed bag, but it contains a massive win for transparency. While the court found that a large chunk of the claims were preempted by federal regulations, meaning federal law takes priority over state-level consumer protection suits, they specifically carved out space for the maximum strength labeling claims to move forward. This means the tea is officially boiling. The court is saying that just because the FDA allows a product to be sold does not give a company a free pass to use marketing language that might trick a regular person into thinking the product is more powerful than it actually is. Who is On The Hook
In the world of multidistrict litigation, the net is usually cast wide. While the specific list of defendants in this stage of the appeal focuses on the major manufacturers of oral decongestants, the shadow falls on any company that relies on superlative marketing. We are talking about the giants of the consumer packaged goods (CPG) world. These are the same conglomerates that often own our favorite snack brands, sparkling water companies, and "functional" beverage lines.
Because this is an MDL, it represents a consolidation of many different lawsuits from across the country. This is not just one person complaining about a stuffy nose. This is a coordinated effort by legal teams representing thousands of consumers who feel that the "maximum strength" promise was a hollow marketing gimmick.
The defendants are currently looking at a revived legal battle that they thought was largely settled. For the corporate suits, this is a nightmare scenario because it keeps the discovery process alive and keeps their marketing tactics under a microscope. They called BS on 'maximum strength'
The core of the "maximum strength" beef is actually pretty simple. The plaintiffs argue that when a consumer sees those words, they expect a higher level of efficacy or a higher dosage than the standard version of the product. The allegations suggest that in many cases, the oral decongestants labeled as maximum strength did not actually provide a statistically significant increase in relief compared to regular versions, or that the dosage was not actually the "maximum" that could be safely administered.
This gets into the nitty-gritty of how we perceive value. In the food and beverage world, we see this all the time with labels like "extra bold," "superfood infused," or "triple filtered." If those terms are just vibes and not backed by data, the legal system is starting to say "hold up."
The Second Circuit's decision to revive these specific claims suggests that "maximum strength" is a factual representation, not just an opinion. If you say a coffee is "delicious," that is puffery because taste is subjective. If you say a pill is "maximum strength," that implies a measurable standard.
The plaintiffs are digging into the gap between what the marketing department says and what the lab results show. They are alleging that companies exploited consumer desperation for relief to charge a premium for products that were essentially standard grade. Financial Fallout
While the exact settlement or damages figures are not yet public for this specific revival, the financial stakes in MDL cases are astronomical. When you consider the sheer volume of oral decongestants sold in the United States every year, even a small "price premium" (the extra dollar or two you pay for the fancy label) adds up to hundreds of millions of dollars.
If these claims eventually lead to a settlement or a jury verdict, we are looking at a potential payout that could rival the biggest consumer protection cases in history. Beyond the direct payments to consumers, the companies are facing massive legal fees. Fighting a case in the Second Circuit is not cheap.
But the real financial fallout is the "rebranding" cost. If the court eventually rules that these labels are deceptive, every single box on every shelf in America will have to be changed. That means new packaging design, pulling old stock, and potentially losing the brand equity built up over decades. For the food and beverage industry, which often shares the same supply chains and marketing agencies as these pharmaceutical giants, the warning is clear: deceptive labels are an expensive liability. Big Tobacco Parallels
It is impossible to look at this case without thinking about the "Light" and "Low Tar" cigarette era. Decades ago, tobacco companies used those terms to imply a safer product, even though the health risks were largely the same. The courts eventually stepped in and gutted that terminology because it was fundamentally misleading to the average consumer.
We are seeing a similar pattern emerge in the health, food, and wellness space. Consumers are increasingly skeptical of big-box claims. The "maximum strength" lawsuit is part of a broader movement toward radical transparency. Just as the tobacco industry was forced to drop the "light" branding, we might be heading toward a future where "maximum," "pure," and "natural" are strictly regulated terms with heavy legal consequences if misused.
Sources and methodology
Reported from the public datasets below.